Applications of CRISPR/Cas technology against drug-resistant lung cancers: an update
Crossref DOI link: https://doi.org/10.1007/s11033-022-07766-7
Published Online: 2022-09-12
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chaudhary, Mayank
Sharma, Pooja
Mukherjee, Tapan Kumar
Text and Data Mining valid from 2022-09-12
Version of Record valid from 2022-09-12
Article History
Received: 28 March 2022
Accepted: 1 July 2022
First Online: 12 September 2022
Declarations
:
: The authors declare no conflict of interest.
: Not applicable.